We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00920712
First Posted: June 15, 2009
Last Update Posted: April 19, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Shanghai University of Traditional Chinese Medicine
  Purpose
The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.

Condition Intervention
Gastritis Drug: Weiqi decotion

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment

Further study details as provided by Shanghai University of Traditional Chinese Medicine:

Primary Outcome Measures:
  • Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change [ Time Frame: 12 weeks ]

Secondary Outcome Measures:
  • Indicates of liver and renal function [ Time Frame: 12 weeks ]

Enrollment: 200
Study Start Date: August 2009
Study Completion Date: July 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Weiqi decoction Drug: Weiqi decotion
Decoction ,two times a day
Placebo Comparator: low dose of Weiqi decoction Drug: Weiqi decotion
Decoction ,two times a day

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of Chronic Atrophic Gastritis
  • Male of female patients between 18-65 years old
  • Written informed consent

Exclusion Criteria:

  • Combine with malignant pathology on epithelial dysplasia of gastric mucosa
  • Combine with duodenal ulcer or gastric ulcer
  • Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
  • Pregnancy or breast feeding women, or unwilling to have contraception.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00920712


Locations
China, Shanghai
Longhua hospital
Shanghai, Shanghai, China, 200032
Sponsors and Collaborators
Shanghai University of Traditional Chinese Medicine
Investigators
Study Director: Xie Jianqun, Phd Shanghai University of Chinese Medicine
  More Information

Responsible Party: Shanghai University of Traditional Chinese Medicine
ClinicalTrials.gov Identifier: NCT00920712     History of Changes
Other Study ID Numbers: SHTCM-001
First Submitted: June 11, 2009
First Posted: June 15, 2009
Last Update Posted: April 19, 2016
Last Verified: August 2009

Keywords provided by Shanghai University of Traditional Chinese Medicine:
chronic atrophic gastritis
Traditional Chinese Medicine

Additional relevant MeSH terms:
Gastritis
Gastritis, Atrophic
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Stomach Diseases


To Top